Skip to main content
lexblog.com/lib/GG0SCV1Xviewrecordjson
{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "FDA issued guidance on statistical considerations for clinical trials during the COVID-19 public health emergency",
    "url": "https://www.lexblog.com/2020/06/19/fda-issued-guidance-on-statistical-considerations-for-clinical-trials-during-the-covid-19-public-health-emergency/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-GG0SCV1X",
        "url": "https://www.lexblog.com/lib/GG0SCV1X/"
    },
    "datePublished": "2020-06-19T13:28:54-04:00",
    "dateModified": "2022-07-22T13:51:07-04:00",
    "author": {
        "@type": "Person",
        "name": "John D. Kendzior, Ryan Pate"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Reed Smith LLP"
    },
    "organizationScope": "at-publication",
    "isPartOf": "Health Industry Washington Watch",
    "about": "Health Care and Life Sciences",
    "sourceUrl": "https://www.healthindustrywashingtonwatch.com/?p=20318",
    "sourceStability": "may-move"
}